A call for standardized naming and reporting of human ESC and iPSC lines.

International Stem Cell Registry, Department of Cell Biology, University of Massachusetts Medical School, Shrewsbury, MA 01545, USA.
Cell stem cell (Impact Factor: 22.15). 04/2011; 8(4):357-9. DOI: 10.1016/j.stem.2011.03.002
Source: PubMed

ABSTRACT Human embryonic and induced pluripotent stem cell lines are being generated at a rapid pace and now number in the thousands. We propose a standard nomenclature and suggest the use of a centralized database for all cell line names and a minimum set of information for reporting new derivations.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Human stem cell research has gaps in capturing and exploiting the results of past and current research.•We now propose a concerted plan that could be taken to foster a more collaborative approach.•We describe the creation of a definitive centralized database repository for stem cell groups.•We suggest computational models for stem cell projects could increase efficiency and may encourage collaboration.•We propose the development of minimum information about stem cell experiments to build confidence in the field.
    Drug Discovery Today 10/2014; 20(2). DOI:10.1016/j.drudis.2014.10.006 · 5.96 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cell-line misidentification and contamination with microorganisms, such as mycoplasma, together with instability, both genetic and phenotypic, are among the problems that continue to affect cell culture. Many of these problems are avoidable with the necessary foresight, and these Guidelines have been prepared to provide those new to the field and others engaged in teaching and instruction with the information necessary to increase their awareness of the problems and to enable them to deal with them effectively. The Guidelines cover areas such as development, acquisition, authentication, cryopreservation, transfer of cell lines between laboratories, microbial contamination, characterisation, instability and misidentification. Advice is also given on complying with current legal and ethical requirements when deriving cell lines from human and animal tissues, the selection and maintenance of equipment and how to deal with problems that may arise.British Journal of Cancer advance online publication, 12 August 2014; doi:10.1038/bjc.2014.166
    British Journal of Cancer 08/2014; 111(6). DOI:10.1038/bjc.2014.166 · 4.82 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There is growing recognition of the potential value of human induced pluripotent stem cells (hiPSC) for understanding disease and identifying drugs targets. This has been reflected in the establishment of multiple large-scale hiPSC initiatives worldwide. Representatives of these met recently at a workshop supported by the Welcome Trust in the UK and in a focus session at the 2014 ISSCR annual meeting in Vancouver. The purpose was to discuss strategies for making thousands of hiPSC lines widely available with as few restrictions as possible while retaining financial viability and donor privacy. The outcome of these discussions is described here. Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.
    12/2014; 3(6):931-9. DOI:10.1016/j.stemcr.2014.11.006